New York State Common Retirement Fund’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
148,722
+22,754
+18% +$557K ﹤0.01% 1232
2025
Q4
$3.37M Buy
125,968
+35,799
+40% +$922K ﹤0.01% 1190
2025
Q3
$2.4M Buy
90,169
+41,800
+86% +$1.08M ﹤0.01% 1372
2025
Q2
$1.11M Sell
48,369
-33,196
-41% -$824K ﹤0.01% 1623
2025
Q1
$2.36M Buy
81,565
+11,075
+16% +$354K ﹤0.01% 1315
2024
Q4
$2.62M Hold
70,490
﹤0.01% 1322
2024
Q3
$3.42M Buy
70,490
+4,763
+7% +$209K ﹤0.01% 1232
2024
Q2
$2.63M Buy
65,727
+11,738
+22% +$486K ﹤0.01% 1373
2024
Q1
$2.37M Buy
53,989
+301
+0.6% +$15.5K ﹤0.01% 1403
2023
Q4
$3.32M Buy
53,688
+5,361
+11% +$282K ﹤0.01% 1261
2023
Q3
$2.22M Sell
48,327
-14,789
-23% -$807K ﹤0.01% 1405
2023
Q2
$3.63M Buy
63,116
+3,330
+6% +$148K ﹤0.01% 1293
2023
Q1
$2.24M Buy
59,786
+31,253
+110% +$1.02M ﹤0.01% 1494
2022
Q4
$799K Buy
28,533
+1,787
+7% +$51.9K ﹤0.01% 2079
2022
Q3
$752K Buy
26,746
+142
+0.5% +$4.64K ﹤0.01% 2118
2022
Q2
$926K Buy
26,604
+204
+0.8% +$7.28K ﹤0.01% 2057
2022
Q1
$948K Sell
26,400
-304
-1% -$8.62K ﹤0.01% 2130
2021
Q4
$622K Sell
26,704
-94
-0.4% -$1.92K ﹤0.01% 2327
2021
Q3
$509K Sell
26,798
-5,606
-17% -$110K ﹤0.01% 2456
2021
Q2
$653K Buy
32,404
+304
+0.9% +$5.73K ﹤0.01% 2453
2021
Q1
$588K Hold
32,100
﹤0.01% 2375
2020
Q4
$646K Hold
32,100
﹤0.01% 2223
2020
Q3
$602K Hold
32,100
﹤0.01% 2126
2020
Q2
$721K Hold
32,100
﹤0.01% 2042
2020
Q1
$476K Hold
32,100
﹤0.01% 2065
2019
Q4
$619K Sell
32,100
-5,800
-15% -$111K ﹤0.01% 2181
2019
Q3
$752K Sell
37,900
-13,289
-26% -$277K ﹤0.01% 2126
2019
Q2
$1.08M Hold
51,189
﹤0.01% 1973
2019
Q1
$1.05M Buy
51,189
+3,003
+6% +$67.3K ﹤0.01% 1938
2018
Q4
$959K Buy
48,186
+10,286
+27% +$203K ﹤0.01% 1935
2018
Q3
$729K Sell
37,900
-4,820
-11% -$85.9K ﹤0.01% 2251
2018
Q2
$652K Hold
42,720
﹤0.01% 2334
2018
Q1
$801K Hold
42,720
﹤0.01% 2144
2017
Q4
$822K Hold
42,720
﹤0.01% 2141
2017
Q3
$763K Hold
42,720
﹤0.01% 2153
2017
Q2
$763K Sell
42,720
-1
-0% -$16 ﹤0.01% 2195
2017
Q1
$619K Buy
42,721
+401
+0.9% +$6.3K ﹤0.01% 2289
2016
Q4
$780K Hold
42,320
﹤0.01% 2167
2016
Q3
$803K Buy
42,320
+9,720
+30% +$176K ﹤0.01% 2100
2016
Q2
$526K Hold
32,600
﹤0.01% 2258
2016
Q1
$391K Hold
32,600
﹤0.01% 2347
2015
Q4
$464K Hold
32,600
﹤0.01% 2361
2015
Q3
$381K Buy
32,600
+8,219
+34% +$123K ﹤0.01% 2440
2015
Q2
$429K Buy
+24,381
New +$380K ﹤0.01% 2584

Other funds holding AMPH

New York State Common Retirement Fund's AMPH Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Amphastar Pharmaceuticals (AMPH) stake by 18% in Q1 2026, buying an estimated $557K and bringing the position to 148,722 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

New York State Common Retirement Fund first reported a position in AMPH in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.63M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • New York State Common Retirement Fund held 148,722 shares of Amphastar Pharmaceuticals worth $2.91M as of Q1 2026.
  • New York State Common Retirement Fund bought 22,754 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $557K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1232 holding.
  • New York State Common Retirement Fund first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • New York State Common Retirement Fund's Amphastar Pharmaceuticals position peaked at $3.63M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.